Translations:Management of obesity/4/ja: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

4 March 2024

  • curprev 16:4816:48, 4 March 2024 Fire talk contribs 269 bytes +269 Created page with "2021年6月、米国食品医薬品局(FDA)は、成人の長期体重管理薬として、「ウゴービ」の商品名で販売されているセマグルチド注射剤を承認した。軽度の胃腸の副作用とともに6~12%の体重減少を伴う。"